Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q61085205 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010850.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q61085205 | ||
| 024 | ‡a 0000-0002-9243-541X ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q61085205 | ||
| 100 | 0 | ‡a Nathaniel J Hart ‡9 ast | |
| 400 | 0 | ‡a Nathaniel J. Hart ‡c researcher ORCID ID = 0000-0002-9243-541X ‡9 en | |
| 400 | 0 | ‡a Nathaniel J Hart ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Age-Dependent Decline in the Coordinated [Ca2+] and Insulin Secretory Dynamics in Human Pancreatic Islets. | ||
| 670 | ‡a Author's Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling | ||
| 670 | ‡a Author's Cystic fibrosis-related diabetes is caused by islet loss and inflammation. | ||
| 670 | ‡a Author's Function and expression of sulfonylurea, adrenergic, and glucagon-like peptide 1 receptors in isolated porcine islets | ||
| 670 | ‡a Author's Hetero-bivalent GLP-1/glibenclamide for targeting pancreatic β-cells. | ||
| 909 | ‡a (orcid) 000000029243541x ‡9 1 | ||
| 919 | ‡a heterobivalentglp1glibenclamidefortargetingpancreaticβcells ‡A Hetero-bivalent GLP-1/glibenclamide for targeting pancreatic β-cells. ‡9 1 | ||
| 919 | ‡a functionandexpressionofsulfonylureaadrenergicandglucagonlikepeptide1receptorsinisolatedporcineislets ‡A Function and expression of sulfonylurea, adrenergic, and glucagon-like peptide 1 receptors in isolated porcine islets ‡9 1 | ||
| 919 | ‡a cysticfibrosisrelateddiabetesiscausedbyisletlossandinflammation ‡A Cystic fibrosis-related diabetes is caused by islet loss and inflammation. ‡9 1 | ||
| 919 | ‡a agedependenthumanβcellproliferationinducedbyglucagonlikepeptide1andcalcineurinsignaling ‡A Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling ‡9 1 | ||
| 919 | ‡a agedependentdeclineinthecoordinatedandinsulinsecretorydynamicsinhumanpancreaticislets ‡A Age-Dependent Decline in the Coordinated [Ca2+] and Insulin Secretory Dynamics in Human Pancreatic Islets. ‡9 1 | ||
| 996 | ‡2 ISNI|0000000081662559 | ||
| 996 | ‡2 NTA|432137904 | ||
| 996 | ‡2 J9U|987007354707005171 | ||
| 996 | ‡2 LC|no2019001146 | ||
| 996 | ‡2 NLA|000035870059 | ||
| 996 | ‡2 SUDOC|234247576 | ||
| 996 | ‡2 NTA|11500274X | ||
| 996 | ‡2 LC|n 78087723 | ||
| 996 | ‡2 LC|nb2005002530 | ||
| 996 | ‡2 ISNI|0000000499929863 | ||
| 996 | ‡2 LC|no2016062710 | ||
| 996 | ‡2 LC|no2020068689 | ||
| 996 | ‡2 ISNI|0000000395827571 | ||
| 996 | ‡2 LC|n 2014058985 | ||
| 996 | ‡2 NII|DA08375696 | ||
| 996 | ‡2 DNB|172126959 | ||
| 996 | ‡2 RERO|A003350120 | ||
| 996 | ‡2 LC|n 89608300 | ||
| 996 | ‡2 NTA|412581663 | ||
| 996 | ‡2 LC|n 2014062721 | ||
| 996 | ‡2 SUDOC|177611243 | ||
| 996 | ‡2 LC|no2019139639 | ||
| 996 | ‡2 BNF|12282372 | ||
| 996 | ‡2 ISNI|0000000029512692 | ||
| 996 | ‡2 DNB|1157689469 | ||
| 996 | ‡2 LC|n 89103892 | ||
| 996 | ‡2 ISNI|0000000032453320 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
